Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes

Fig. 4

Copy number variations in parental SH-SY5Y and MSDACs. Representative copy number variation charts showing gain in Chr.1, 158.35–160.00 MB; Chr.7, 114.084–114.115 MB; Chr.8, 39.25–39.40 MB, and in Chr.8, 84.50–85.75 MB, corresponding to the coding regions of CD1C, FOXP2, ADAM5, and RALYL, respectively, in MSDACs compared with SH-SY5Y cells

Back to article page